Navigation Links
COPAN Announces Strategic Global Distribution Partnership with Siemens
Date:6/6/2011

MURRIETA, Calif., June 6, 2011 /PRNewswire/ -- COPAN announced a strategic partnership with Siemens for the global distribution of COPAN WASP®: Walk-Away Specimen Processor in New Orleans, Louisiana, during the ASM's 111th General Meeting.

The strategic distribution partnership announcement came in light of the worldwide launch of WASPLab™, which is a barcode driven and conveyor-connected specimen processing system which utilizes robotic plate management and image analysis to automate specimen processing and workup in Microbiology. In a field of increasing workloads and diminishing resources, WASPLab™ was a welcomed innovation and well received by attendees of the 21st ECCMID General Meeting and ASM's 111th General Meeting.

"The distribution agreement with Siemens MicroScan® portfolio complements COPAN's vision of converging technologies to improve front-end workflow in Bacteriology, which until recently had been perceived as too complex to automate," says Norman Sharples, COPAN Diagnostics' Executive VP. "The synergy of this partnership presents laboratories with a streamlined solution for single piece workflow for pre-analytics in Microbiology to improve efficiencies, increase traceability and expand services within current space, labor and expense limitations, to and ultimately improve patient care. This agreement is particularly exciting for the US hospital market as it merges Siemens' strong reputation in Microbiology and COPAN's innovation in pre-analytics," concludes Sharples.

About COPAN Group

With a reputation for innovation in preanalytics, COPAN is the leading manufacturer of collection and transport systems in the world. COPAN offers a complete line of automation and a range of microbial sampling products used for traditional culture analysis and molecular diagnostic assays. For more information, visit www.copanusa.com


'/>"/>
SOURCE Copan Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Copan Redefines Automated Specimen Processing with Groundbreaking New Features
2. COPAN Secures Japanese Patent for its Flocked Swab Innovation
3. COPAN Files New Patents Following the Development of High Nucleic Acid Yield Flocked Swabs
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
6. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
7. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
8. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
9. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
10. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
11. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) ... , and named its founder as Diplomat,s chief information ... Tennessee , will operate under Diplomat subsidiary Envoy ... for health care partners to include IT outsourcing, consulting, ... "In an interoperable world, technology delivers comprehensive insight and ...
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/25/2017)... , Sept. 25, 2017  EpiVax, Inc., ... vaccine design, and immune-engineering today announced the launch ... the development of personalized therapeutic cancer vaccines. EpiVax ... provided exclusive access to enabling technologies to the ... MBA will lead EpiVax Oncology as Chief Executive ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... While it’s often important to take certain medications during the night, finding ... identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX to ... the need to turn on a light when taking medication during the night, allowing ...
(Date:10/13/2017)... N.Y (PRWEB) , ... October 13, 2017 , ... Lori ... became a member of ElderCounsel, a national organization of elder law and special needs ... changing laws and rules. It also provides a forum to network with elder law ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual Kids ... Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, ... run is geared towards children of all ages; it is a non-competitive, non-timed event, ...
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... ... 12, 2017 , ... IsoComforter, Inc. ( https://isocomforter.com ), one of ... innovative new design of the shoulder pad. The shoulder pad provides optimal support ... your pain while using cold therapy. By utilizing ice and water that is circulated ...
Breaking Medicine News(10 mins):